Yellow fever vaccine - Serum Institute of India
Alternative Names: SII Yellow Fever Vaccine - Serum Institute of India; SII-YFVLatest Information Update: 07 Dec 2023
At a glance
- Originator Serum Institute of India
- Class Attenuated vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Yellow fever
Most Recent Events
- 11 May 2023 Phase-III clinical trials in Yellow fever (In adults, In children, In adolescents, Prevention) in Kenya (Parenteral) (NCT05421611)
- 16 Sep 2022 Phase-III clinical trials in Yellow fever (In infants, Prevention) in Gambia (unspecified route) (NCT05447377)
- 16 Sep 2022 Phase-III clinical trials in Yellow fever (In infants, Prevention) in Mali (unspecified route) (NCT05447377)